Robert W. Robey
Impact in
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 121
- Drug Transport and Resistance Mechanisms 93
-
- Cancer therapeutics and mechanisms 31
- Histone Deacetylase Inhibitors Research 22
- Epigenetics and DNA Methylation 11
- Co-authors
- Susan E. Bates (110 shared papers)Tito Fojo (30 shared papers)Orsolya Polgár (14 shared papers)Michael M. Gottesman (31 shared papers)Antonio Tito Fojo (7 shared papers)Thomas Litman (13 shared papers)Matthew D. Hall (7 shared papers)Suresh V. Ambudkar (25 shared papers)
- Journals
- Cancer Research (12 papers)Clinical Cancer Research (8 papers)Blood (8 papers)Molecular Pharmacology (5 papers)Cancer Biology & Therapy (5 papers)
- Partner nations
- United StatesChinaHungary
In The Last Decade
Robert W. Robey
156 papers receiving 13.6k citations
Robert W. Robey's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 9.2k
- Pediatrics, Perinatology and Child Health 2.3k
- Molecular Biology 7.3k
- Infectious Diseases 1.6k
- Cancer Research 1.2k
Countries citing papers authored by Robert W. Robey
This map shows the geographic impact of Robert W. Robey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Robey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Robey more than expected).
Fields of papers citing papers by Robert W. Robey
This network shows the impact of papers produced by Robert W. Robey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Robey. The network helps show where Robert W. Robey may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. Robey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revisiting the role of ABC transporters in multidrug-resistant cancer Hit paper breakdown → | 2018 | 1382 |
| 2 | Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Hit paper breakdown → | 1999 | 674 |
| 3 | Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. | 2002 | 435 |
| 4 | 2001 | 367 | |
| 5 | 2008 | 361 | |
| 6 | Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | 2001 | 353 |
| 7 | 2008 | 333 | |
| 8 | 2007 | 306 | |
| 9 | 2003 | 300 | |
| 10 | Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. | 2001 | 296 |
| 11 | 2004 | 296 | |
| 12 | Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. | 2003 | 258 |
| 13 | 2007 | 257 | |
| 14 | 1999 | 250 | |
| 15 | 2010 | 224 | |
| 16 | Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. | 1999 | 216 |
| 17 | 2001 | 215 | |
| 18 | Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. | 2002 | 207 |
| 19 | 2008 | 191 | |
| 20 | MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. | 2002 | 190 |
About Robert W. Robey
Robert W. Robey is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Infectious Diseases and Surgery, having authored 159 papers that have together received 13.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (93 papers), Cancer therapeutics and mechanisms (31 papers), Pharmacological Effects and Toxicity Studies (26 papers), Histone Deacetylase Inhibitors Research (22 papers), HIV/AIDS drug development and treatment (13 papers), Microtubule and mitosis dynamics (11 papers), Epigenetics and DNA Methylation (11 papers) and Trace Elements in Health (11 papers). The work is most often cited by research in Oncology (9.2k citations), Pediatrics, Perinatology and Child Health (2.3k citations), Molecular Biology (7.3k citations), Infectious Diseases (1.6k citations) and Cancer Research (1.2k citations). Robert W. Robey has collaborated with scholars based in United States, China and Hungary. Frequent co-authors include Susan E. Bates, Tito Fojo, Orsolya Polgár, Michael M. Gottesman, Antonio Tito Fojo, Thomas Litman, Matthew D. Hall, Suresh V. Ambudkar, Kristen M. Pluchino and Michael Dean. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Blood, Molecular Pharmacology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.